<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Jpn J Cancer Res</journal-id><journal-id journal-id-type="iso-abbrev">Jpn. J. Cancer Res</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1349-7006a</journal-id><journal-id journal-id-type="publisher-id">CAS</journal-id><journal-title-group><journal-title>Japanese Journal of Cancer Research : Gann</journal-title></journal-title-group><issn pub-type="ppub">0910-5050</issn><issn pub-type="epub">1876-4673</issn><publisher><publisher-name>Blackwell Publishing Ltd</publisher-name><publisher-loc>Oxford, UK</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">1905707</article-id><article-id pub-id-type="pmc">5918486</article-id><article-id pub-id-type="doi">10.1111/j.1349-7006.1991.tb01894.x</article-id><article-id pub-id-type="publisher-id">CAE613</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>A Cooperative Randomized Study on Tegafur plus Mitomycin C versus Combined Tegafur and Uracil plus Mitomycin C in the Treatment of Advanced Gastric Cancer</article-title></title-group><contrib-group><contrib id="cr1" contrib-type="author"><name><surname>Kurihara</surname><given-names>Minoru</given-names></name><xref ref-type="aff" rid="a1"><sup>1</sup></xref></contrib><contrib id="cr2" contrib-type="author"><name><surname>Izumi</surname><given-names>Tuguhiko</given-names></name><xref ref-type="aff" rid="a1"><sup>1</sup></xref></contrib><contrib id="cr3" contrib-type="author"><name><surname>Yoshida</surname><given-names>Shigeaki</given-names></name><xref ref-type="aff" rid="a2"><sup>2</sup></xref></contrib><contrib id="cr4" contrib-type="author"><name><surname>Ohkubo</surname><given-names>Toshiharu</given-names></name><xref ref-type="aff" rid="a3"><sup>3</sup></xref></contrib><contrib id="cr5" contrib-type="author"><name><surname>Suga</surname><given-names>Shoji</given-names></name><xref ref-type="aff" rid="a4"><sup>4</sup></xref></contrib><contrib id="cr6" contrib-type="author"><name><surname>Kiyohashi</surname><given-names>Atsushi</given-names></name><xref ref-type="aff" rid="a5"><sup>5</sup></xref></contrib><contrib id="cr7" contrib-type="author"><name><surname>Yaosaka</surname><given-names>Tohru</given-names></name><xref ref-type="aff" rid="a6"><sup>6</sup></xref></contrib><contrib id="cr8" contrib-type="author"><name><surname>Takahashi</surname><given-names>Hiromu</given-names></name><xref ref-type="aff" rid="a7"><sup>7</sup></xref></contrib><contrib id="cr9" contrib-type="author"><name><surname>Ito</surname><given-names>Tetsuo</given-names></name><xref ref-type="aff" rid="a8"><sup>8</sup></xref></contrib><contrib id="cr10" contrib-type="author"><name><surname>Sasai</surname><given-names>Tadashi</given-names></name><xref ref-type="aff" rid="a9"><sup>9</sup></xref></contrib><contrib id="cr11" contrib-type="author"><name><surname>Akiya</surname><given-names>Toshikazu</given-names></name><xref ref-type="aff" rid="a10"><sup>10</sup></xref></contrib><contrib id="cr12" contrib-type="author"><name><surname>Akazawa</surname><given-names>Shugo</given-names></name><xref ref-type="aff" rid="a11"><sup>11</sup></xref></contrib><contrib id="cr13" contrib-type="author"><name><surname>Betsuyaku</surname><given-names>Takashi</given-names></name><xref ref-type="aff" rid="a12"><sup>12</sup></xref></contrib><contrib id="cr14" contrib-type="author"><name><surname>Taguchi</surname><given-names>Susumu</given-names></name><xref ref-type="aff" rid="a13"><sup>13</sup></xref></contrib></contrib-group><aff id="a1"><label><sup>1</sup></label>Department of Gastroenterology, Toyosu Hospital, Showa University, 4&#x02010;1&#x02010;18, Koto&#x02010;ku, Tokyo 135</aff><aff id="a2"><label><sup>2</sup></label>Department of Internal Medicine, National Cancer Center Hospital, 5&#x02010;1&#x02010;1, Tsukiji, Chuo&#x02010;ku, Tokyo 104</aff><aff id="a3"><label><sup>3</sup></label>First Department of Internal Medicine, Hiraga Hospital, 10&#x02010;18, Kotobukicho, Yokote 013</aff><aff id="a4"><label><sup>4</sup></label>Department of Gastroenterology, Nagoya National Hospital, 4&#x02010;1&#x02010;1, Sannomaru, Naka&#x02010;ku, Nagoya 460</aff><aff id="a5"><label><sup>5</sup></label>Department of Internal Medicine, Kitazato University, 1&#x02010;5&#x02010;1, Kitazato, Sagamihara 228</aff><aff id="a6"><label><sup>6</sup></label>Department of Gastroenterology, Sapporo Kosei Hospital, 7&#x02010;3, Kita Yonjonishi, Chuo&#x02010;ku, Sapporo 060</aff><aff id="a7"><label><sup>7</sup></label>Department of Clinical Cancer Chemotherapy, The Research Institute for Tuberculosis and Cancer, Tohoku University, 1&#x02010;1, Seiryomachi, Aoba&#x02010;ku, Sendai 980</aff><aff id="a8"><label><sup>8</sup></label>Department of Internal Medicine, Juntendo, University, 2&#x02010;1&#x02010;2, Hongo, Bunkyo&#x02010;ku, Tokyo 113</aff><aff id="a9"><label><sup>9</sup></label>Department of Internal Medicine, National Okayama Hospital, 2&#x02010;13&#x02010;1, Minamikata, Okayama 700</aff><aff id="a10"><label><sup>10</sup></label>Department of Internal Medicine, Gunma Cancer Center Tohmo Hospital, 617&#x02010;1, Takabayashi, Ohta 373</aff><aff id="a11"><label><sup>11</sup></label>Department of Gastroenterology, Saitama Cancer Center Hospital, 81 Komuro, Inamachi, Kitaadachi&#x02010;gun 362</aff><aff id="a12"><label><sup>12</sup></label>Department of Gastroenterology, National Sapporo Hospital, 2&#x02010;chome Yonjo Kikusui, Shiroishi&#x02010;ku, Sapporo 003</aff><aff id="a13"><label><sup>13</sup></label><sup>13</sup>Second Department of Internal Medicine, Showa University, 1&#x02010;5&#x02010;8 Hatanodai, Shinagawa&#x02010;ku, Tokyo 142</aff><pub-date pub-type="ppub"><month>5</month><year>1991</year></pub-date><volume>82</volume><issue>5</issue><issue-id pub-id-type="doi">10.1111/cas.1991.82.issue-5</issue-id><fpage>613</fpage><lpage>620</lpage><history>
(Received August 16, 1990/Accepted February 6, 1991)</history><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:CAS-82-613.pdf"/><abstract><p>A randomized controlled trial involving 13 institutions in Japan was conducted in order to compare the efficacy of tegafur plus mitomycin C (MMC) (Regimen A) and UFT (a combination of uracil and tegafur at a molar ratio of 4 to 1) plus MMC (Regimen B) for patients with advanced gastric cancer, who had not received any prior cancer chemotherapy. Regimen A (tegafur+MMC) consisted of 5 mg of MMC/m<sup>2</sup>/week given intravenously, and 500 mg of tegafur/m<sup>2</sup>/day given orally. Regimen B consisted of the same schedule of MMC and 375 mg of UFT/m<sup>2</sup>/day given orally. One hundred and eighty&#x02010;six patients with primary gastric cancer were entered; 183 were eligible and 3 were ineligible for the study. A total of 169 were evaluable for efficacy of the treatment, including 90 patients with Regimen A and 79 with Regimen B. A response rate of 7.8% (7/90 cases) for Regimen A and one of 25.3% (20/79 cases) for Regimen B were obtained, indicating a significantly higher response rate for Regimen B according to the Criteria for Evaluating Efficacy of Chemotherapy /Radiation Therapy in the Treatment of Gastric Cancer (<italic>P</italic>= 0.004), Regarding side effects, no marked differences in either severity or incidence were observed between the two groups. The group assigned to Regimen B showed a significant survival advantage after adjustment for major prognostic factors using a proportional hazards model (<italic>P</italic>=0.0398). Moreover, a close correlation of antitumor effect and survival duration was found when the above criteria were used.</p></abstract><kwd-group><kwd id="k1">Randomized study</kwd><kwd id="k2">Tegafur</kwd><kwd id="k3">Tegafur and uracil</kwd><kwd id="k4">MMC</kwd><kwd id="k5">Gastric cancer</kwd></kwd-group><counts><ref-count count="21"/><page-count count="8"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>May 1991</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.6.9 mode:remove_FC converted:04.11.2015</meta-value></custom-meta></custom-meta-group></article-meta></front><back><ref-list id="ss1"><title>REFERENCES</title><ref id="b1"><label>1</label><mixed-citation publication-type="journal" id="cit1">
)
<string-name><surname>Fujii</surname>
,
<given-names>S.</given-names></string-name>
,
<string-name><surname>Ikenaka</surname>
,
<given-names>K.</given-names></string-name>
,
<string-name><surname>Fukushima</surname>
,
<given-names>M.</given-names></string-name>
and
<string-name><surname>Shirasaka</surname>
,
<given-names>T.</given-names></string-name><article-title>Effect of uracil and its derivatives on antitumor activity of 5 &#x02010;fluorouracil and 1&#x02010;(2&#x02010;tetrahydrofuryl)&#x02010;5&#x02010;fluorouracil</article-title>
.
<source>Gann</source>
,
<volume>69</volume>
,
<fpage>763</fpage>
&#x02013;
<lpage>772</lpage>
(
<year>1978</year>
).
<pub-id pub-id-type="pmid">750271</pub-id></mixed-citation></ref><ref id="b2"><label>2</label><mixed-citation publication-type="journal" id="cit2">
)
<string-name><surname>Fujii</surname>
,
<given-names>S.</given-names></string-name>
,
<string-name><surname>Kitano</surname>
,
<given-names>S.</given-names></string-name>
,
<string-name><surname>Ikenaka</surname>
,
<given-names>K.</given-names></string-name>
and
<string-name><surname>Shirasaka</surname>
,
<given-names>T.</given-names></string-name><article-title>Effect of coadministration of uracil or cytosine on the antitumor activity of clinical doses of 1&#x02010; (2 &#x02010;tetrahydrofuryl)&#x02010; 5 &#x02010;fluorouracil and level of 5&#x02010;fluorouracil in rodents</article-title>
.
<source>Gann</source>
,
<volume>70</volume>
,
<fpage>209</fpage>
&#x02013;
<lpage>214</lpage>
(
<year>1979</year>
).
<pub-id pub-id-type="pmid">381088</pub-id></mixed-citation></ref><ref id="b3"><label>3</label><mixed-citation publication-type="book" id="cit3">
)
<string-name><surname>Ogawa</surname>
,
<given-names>M.</given-names></string-name><chapter-title>An overview of chemotherapy for advanced gastric cancer</chapter-title>
.
<italic>In</italic><source>&#x0201c;Diagnosis and Treatment of Upper Gastrointestinal Tumors</source>
&#x0201d;,
ed.
<person-group person-group-type="editor"><name><surname>Friedman</surname><given-names>M.</given-names></name></person-group>
,
<person-group person-group-type="editor"><name><surname>Ogawa</surname><given-names>M.</given-names></name></person-group>
and
<person-group person-group-type="editor"><name><surname>Kisner</surname><given-names>D.</given-names></name></person-group>
,
pp.
<fpage>357</fpage>
&#x02013;
<lpage>369</lpage>
(
<year>1981</year>
).
<publisher-name>Excerpta Medica</publisher-name>
,
Amsterdam
.
</mixed-citation></ref><ref id="b4"><label>4</label><mixed-citation publication-type="book" id="cit4">
)
<string-name><surname>Kurihara</surname>
,
<given-names>M.</given-names></string-name>
,
<string-name><surname>Shirakabe</surname>
,
<given-names>H.</given-names></string-name>
,
<string-name><surname>Izumi</surname>
,
<given-names>T.</given-names></string-name>
,
<string-name><surname>Miyasaka</surname>
,
<given-names>K.</given-names></string-name>
,
<string-name><surname>Maruyama</surname>
,
<given-names>T.</given-names></string-name>
,
<string-name><surname>Sasaki</surname>
,
<given-names>Y.</given-names></string-name>
,
<string-name><surname>Kobayashi</surname>
,
<given-names>S.</given-names></string-name>
and
<string-name><surname>Kamano</surname>
,
<given-names>T.</given-names></string-name><chapter-title>X&#x02010;ray and endoscopy in the evaluation of gastric cancer chemotherapy</chapter-title>
.
<italic>In</italic>
&#x0201c;
<source>Diagnosis and Treatment of Upper Gastrointestinal Tumors</source>
&#x0201d;,
ed.
<person-group person-group-type="editor"><name><surname>Friedman</surname><given-names>M.</given-names></name></person-group>
,
<person-group person-group-type="editor"><name><surname>Ogawa</surname><given-names>M.</given-names></name></person-group>
and
<person-group person-group-type="editor"><name><surname>Kisner</surname><given-names>D.</given-names></name></person-group>
,
pp.
<fpage>428</fpage>
&#x02013;
<lpage>449</lpage>
(
<year>1981</year>
).
<publisher-name>Excerpta Medica</publisher-name>
,
Amsterdam
.
</mixed-citation></ref><ref id="b5"><label>5</label><mixed-citation publication-type="book" id="cit5">
)
<string-name><surname>Suga</surname>
,
<given-names>S.</given-names></string-name>
,
<string-name><surname>Kimura</surname>
,
<given-names>K.</given-names></string-name>
,
<string-name><surname>Yoshida</surname>
,
<given-names>Y.</given-names></string-name>
,
<string-name><surname>Horiuchi</surname>
,
<given-names>T.</given-names></string-name>
and
<string-name><surname>Yokoyama</surname>
,
<given-names>Y.</given-names></string-name><chapter-title>UFTM chemotherapy for gastric cancer: effectiveness and comparison of survival between UFTM and surgical treatment in patients with Borrmann type 4 gastric cancer</chapter-title>
.
<italic>In</italic>
&#x0201c;
<source>Fluoropyrimidines in Cancer Therapy</source>
&#x0201d;,
ed.
<person-group person-group-type="editor"><name><surname>Kimura</surname><given-names>K.</given-names></name></person-group>
,
<person-group person-group-type="editor"><name><surname>Fujii</surname><given-names>S.</given-names></name></person-group>
,
<person-group person-group-type="editor"><name><surname>Ogawa</surname><given-names>M.</given-names></name></person-group>
,
<person-group person-group-type="editor"><name><surname>Bodey</surname><given-names>G. B.</given-names></name></person-group>
and
<person-group person-group-type="editor"><name><surname>Alberto</surname><given-names>P.</given-names></name></person-group>
,
pp.
<fpage>311</fpage>
&#x02013;
<lpage>319</lpage>
(
<year>1984</year>
).
<publisher-name>Excerpta Medica</publisher-name>
,
Amsterdam
.
</mixed-citation></ref><ref id="b6"><label>6</label><mixed-citation publication-type="journal" id="cit6">
)
<string-name><surname>Goto</surname>
,
<given-names>Y.</given-names></string-name>
,
<string-name><surname>Toyota</surname>
,
<given-names>T.</given-names></string-name>
,
<string-name><surname>Asaki</surname>
,
<given-names>S.</given-names></string-name>
,
<string-name><surname>Kikuchi</surname>
,
<given-names>T.</given-names></string-name>
,
<string-name><surname>Koizumi</surname>
,
<given-names>M.</given-names></string-name>
,
<string-name><surname>Ohkubo</surname>
,
<given-names>T.</given-names></string-name>
,
<string-name><surname>Nomura</surname>
,
<given-names>N.</given-names></string-name>
,
<string-name><surname>Mochizuki</surname>
,
<given-names>F.</given-names></string-name>
,
<string-name><surname>Taima</surname>
,
<given-names>T.</given-names></string-name>
,
<string-name><surname>Miura</surname>
,
<given-names>K.</given-names></string-name>
,
<string-name><surname>Sakurada</surname>
,
<given-names>H.</given-names></string-name>
,
<string-name><surname>Shoji</surname>
,
<given-names>T.</given-names></string-name>
,
<string-name><surname>Nakano</surname>
,
<given-names>N.</given-names></string-name>
,
<string-name><surname>Saito</surname>
,
<given-names>H.</given-names></string-name>
,
<string-name><surname>Okano</surname>
,
<given-names>T.</given-names></string-name>
,
<string-name><surname>Shimizu</surname>
,
<given-names>H.</given-names></string-name>
and
<string-name><surname>Fukuo</surname>
,
<given-names>A.</given-names></string-name><article-title>Randomized controlled study of treatment with UFT&#x02010;MMC or UFT&#x02010;ACR for advanced gastric cancer</article-title>
.
<source>Jpn. J. Cancer Chemother.</source>
,
<volume>16</volume>
,
<fpage>2227</fpage>
&#x02013;
<lpage>2233</lpage>
(
<year>1989</year>
)(
in Japanese
).
</mixed-citation></ref><ref id="b7"><label>7</label><mixed-citation publication-type="miscellaneous" id="cit7">
)
<string-name><surname>Kurihara</surname>
,
<given-names>M.</given-names></string-name>
,
<string-name><surname>Miyasaka</surname>
,
<given-names>K.</given-names></string-name>
,
<string-name><surname>Izumi</surname>
,
<given-names>T.</given-names></string-name>
,
<string-name><surname>Maruyama</surname>
,
<given-names>T.</given-names></string-name>
,
<string-name><surname>Sasaki</surname>
,
<given-names>Y.</given-names></string-name>
,
<string-name><surname>Kamano</surname>
,
<given-names>T.</given-names></string-name>
and
<string-name><surname>Yasui</surname>
,
<given-names>A.</given-names></string-name><article-title>Evaluation of cancer chemotherapy on gastric cancer by X&#x02010;ray and endoscopy</article-title>
.
<article-title>Proc. 13th Int. Congr. Chemother.</article-title>
,
pp.
<fpage>282/10</fpage>
&#x02013;
<lpage>15</lpage>
(
<year>1983</year>
).
</mixed-citation></ref><ref id="b8"><label>8</label><mixed-citation publication-type="journal" id="cit8">
)
<string-name><surname>Suga</surname>
,
<given-names>S.</given-names></string-name>
,
<string-name><surname>Kimura</surname>
,
<given-names>K.</given-names></string-name>
,
<string-name><surname>Yokoyama</surname>
,
<given-names>Y.</given-names></string-name>
,
<string-name><surname>Isobe</surname>
,
<given-names>K.</given-names></string-name>
,
<string-name><surname>Yoshida</surname>
,
<given-names>Y.</given-names></string-name>
,
<string-name><surname>Takada</surname>
,
<given-names>T.</given-names></string-name>
,
<string-name><surname>Sato</surname>
,
<given-names>A.</given-names></string-name>
,
<string-name><surname>Kuwabara</surname>
,
<given-names>T.</given-names></string-name>
and
<string-name><surname>Iwase</surname>
,
<given-names>H.</given-names></string-name><article-title>Studies on the designing of chemotherapy for gastric cancer in man, based on the tumor tissue concentration of anticancer agents</article-title>
,
<source>Gastroenterol. Jpn.</source>
,
<volume>17</volume>
,
<fpage>295</fpage>
&#x02013;
<lpage>300</lpage>
(
<year>1982</year>
).
<pub-id pub-id-type="pmid">6216137</pub-id></mixed-citation></ref><ref id="b9"><label>9</label><mixed-citation publication-type="book" id="cit9">
)
<collab collab-type="authors">Japanese Research Society for Gastric Cancer</collab>
,
<chapter-title>Criteria for Evaluating Efficacy of Chemotherapy/Radiation Therapy in the Treatment of Gastric Cancer</chapter-title>
. &#x0201c;
<source>The General Rules for the Gastric Cancer Study</source>
&#x0201d;,
<edition>11th Edition</edition>
,
pp.
<fpage>102</fpage>
&#x02013;
<lpage>105</lpage>
(
<year>1985</year>
).
<publisher-name>Kanehara Shuppan</publisher-name>
,
Tokyo
(
in Japanese
).
</mixed-citation></ref><ref id="b10"><label>10</label><mixed-citation publication-type="journal" id="cit10">
)
<string-name><surname>Cox</surname>
,
<given-names>D. R.</given-names></string-name><article-title>Regression models and life tables</article-title>
.
<source>J. R. Stat. Soc. Ser. B</source>
,
<volume>34</volume>
,
<fpage>187</fpage>
&#x02013;
<lpage>220</lpage>
(
<year>1972</year>
).
</mixed-citation></ref><ref id="b11"><label>11</label><mixed-citation publication-type="book" id="cit11">
)
<string-name><surname>Kurihara</surname>
,
<given-names>M.</given-names></string-name><chapter-title>Indication and prognostic factors</chapter-title>
.
<italic>In</italic>
&#x0201c;
<source>Chemotherapy of Gastric Cancer</source>
&#x0201d;,
ed.
<person-group person-group-type="editor"><name><surname>Kurihara</surname><given-names>M.</given-names></name></person-group>
and
<person-group person-group-type="editor"><name><surname>Nakajima</surname><given-names>T.</given-names></name></person-group>
,
pp.
<fpage>85</fpage>
&#x02013;
<lpage>87</lpage>
(
<year>1981</year>
).
<publisher-name>Shinkooigaku Shuppan</publisher-name>
,
Tokyo
(
in Japanese
).
</mixed-citation></ref><ref id="b12"><label>12</label><mixed-citation publication-type="journal" id="cit12">
)
<string-name><surname>Macdonald</surname>
,
<given-names>J. S.</given-names></string-name>
,
<string-name><surname>Wolley</surname>
,
<given-names>P.</given-names></string-name>
,
<string-name><surname>Smythe</surname>
,
<given-names>T.</given-names></string-name>
,
<string-name><surname>Ueno</surname>
,
<given-names>W.</given-names></string-name>
,
<string-name><surname>Hoth</surname>
,
<given-names>D.</given-names></string-name>
and
<string-name><surname>Schein</surname>
,
<given-names>P. S.</given-names></string-name><article-title>5&#x02010;Fluorouracil, adriamycin and mitomycin C (FAM) combination chemotherapy in the treatment of advanced gastric cancer</article-title>
.
<source>Cancer</source>
,
<volume>44</volume>
,
<fpage>42</fpage>
&#x02013;
<lpage>47</lpage>
(
<year>1979</year>
).
<pub-id pub-id-type="pmid">455263</pub-id></mixed-citation></ref><ref id="b13"><label>13</label><mixed-citation publication-type="journal" id="cit13">
)
<string-name><surname>Moertel</surname>
,
<given-names>C. G.</given-names></string-name>
and
<string-name><surname>Lavin</surname>
,
<given-names>P. T.</given-names></string-name><article-title>Phase II&#x02010;III chemotherapy studies in advanced gastric cancer</article-title>
.
<source>Cancer Treat. Rep.</source>
,
<volume>63</volume>
,
<fpage>1863</fpage>
&#x02013;
<lpage>1869</lpage>
(
<year>1979</year>
).
<pub-id pub-id-type="pmid">393381</pub-id></mixed-citation></ref><ref id="b14"><label>14</label><mixed-citation publication-type="journal" id="cit14">
)
<string-name><surname>Wagener</surname>
,
<given-names>D.</given-names></string-name>
,
<string-name><surname>Yap</surname>
,
<given-names>S.</given-names></string-name>
,
<string-name><surname>Wobbes</surname>
,
<given-names>T.</given-names></string-name>
,
<string-name><surname>Burghouts</surname>
,
<given-names>J.</given-names></string-name>
,
<string-name><surname>Dam</surname>
,
<given-names>F.</given-names></string-name>
,
<string-name><surname>Hillen</surname>
,
<given-names>H.</given-names></string-name>
,
<string-name><surname>Hoogendoorn</surname>
,
<given-names>G.</given-names></string-name>
,
<string-name><surname>Scheerder</surname>
,
<given-names>H.</given-names></string-name>
and
<string-name><surname>Vegt</surname>
,
<given-names>S.</given-names></string-name><article-title>Phase II trial of 5&#x02010;fluorouracil, adriamycin and cisplatin (FAP) in advanced gastric cancer</article-title>
.
<source>Cancer Chemother. Pharmacol</source>
,
<volume>15</volume>
,
<fpage>86</fpage>
&#x02013;
<lpage>87</lpage>
(
<year>1985</year>
).
<pub-id pub-id-type="pmid">4039985</pub-id></mixed-citation></ref><ref id="b15"><label>15</label><mixed-citation publication-type="journal" id="cit15">
)
<string-name><surname>Moertel</surname>
,
<given-names>C. G.</given-names></string-name>
,
<string-name><surname>Rubin</surname>
,
<given-names>J.</given-names></string-name>
,
<string-name><surname>O'Connell</surname>
,
<given-names>M.</given-names></string-name>
,
<string-name><surname>Schutt</surname>
,
<given-names>A.</given-names></string-name>
and
<string-name><surname>Wieand</surname>
,
<given-names>H.</given-names></string-name><article-title>A phase II study of combined 5&#x02010;fluorouracil, doxorubicin, and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomas</article-title>
.
<source>J. Clin. Oncol.</source>
,
<volume>4</volume>
,
<fpage>1053</fpage>
&#x02013;
<lpage>1057</lpage>
(
<year>1986</year>
).
<pub-id pub-id-type="pmid">3014083</pub-id></mixed-citation></ref><ref id="b16"><label>16</label><mixed-citation publication-type="journal" id="cit16">
)
<string-name><surname>Preusser</surname>
,
<given-names>P.</given-names></string-name>
,
<string-name><surname>Wilke</surname>
,
<given-names>H.</given-names></string-name>
and
<string-name><surname>Achterrath</surname>
,
<given-names>W.</given-names></string-name><article-title>Phase II studie mit Etoposid, Adriamycin, Gisplatin (EAP) Beim Primar inoperablen, metastasierten Magen Karzinom</article-title>
.
<source>Tumor Diag. Ther.</source>
,
<volume>8</volume>
,
<fpage>43</fpage>
&#x02013;
<lpage>48</lpage>
(
<year>1987</year>
).
</mixed-citation></ref><ref id="b17"><label>17</label><mixed-citation publication-type="book" id="cit17">
)
<string-name><surname>Romond</surname>
,
<given-names>E. H.</given-names></string-name>
and
<string-name><surname>Macdonald</surname>
,
<given-names>J. S.</given-names></string-name><chapter-title>Chemotherapy of gastric cancer</chapter-title>
.
<italic>In</italic>
&#x0201c;
<source>Gastric Cancer</source>
&#x0201d;,
ed.
<person-group person-group-type="editor"><name><surname>Douglass</surname><given-names>H. O.</given-names><suffix>Jr.</suffix></name></person-group>
,
pp.
<fpage>205</fpage>
&#x02013;
<lpage>220</lpage>
(
<year>1988</year>
).
<publisher-name>Churchill Livingstone</publisher-name>
,
New York
.
</mixed-citation></ref><ref id="b18"><label>18</label><mixed-citation publication-type="journal" id="cit18">
)
<string-name><surname>Arbuck</surname>
,
<given-names>S.</given-names></string-name>
,
<string-name><surname>Silk</surname>
,
<given-names>Y.</given-names></string-name>
,
<string-name><surname>Douglass</surname>
,
<given-names>H.</given-names></string-name>
,
<string-name><surname>Nava</surname>
,
<given-names>H.</given-names></string-name>
,
<string-name><surname>Rustum</surname>
,
<given-names>Y.</given-names></string-name>
and
<string-name><surname>Milliron</surname>
,
<given-names>S.</given-names></string-name><article-title>A phase II trial of 5&#x02010;fluorouracil, doxorubicin, mitomycin C and leucovorin in advanced gastric carcinoma</article-title>
.
<source>Cancer</source>
,
<volume>65</volume>
,
<fpage>2442</fpage>
&#x02013;
<lpage>2445</lpage>
(
<year>1990</year>
).
<pub-id pub-id-type="pmid">2337858</pub-id></mixed-citation></ref><ref id="b19"><label>19</label><mixed-citation publication-type="journal" id="cit19">
)
<string-name><surname>Kurihara</surname>
,
<given-names>M.</given-names></string-name>
and
<string-name><surname>Izumi</surname>
,
<given-names>T.</given-names></string-name><article-title>Chemotherapy of solid tumors &#x02013; evaluation of effects on gastric cancer</article-title>
.
<source>Jpn. J. Cancer Clin.</source>
,
<volume>26</volume>
,
<fpage>652</fpage>
&#x02013;
<lpage>658</lpage>
(
<year>1980</year>
) (
in Japanese
).
</mixed-citation></ref><ref id="b20"><label>20</label><mixed-citation publication-type="journal" id="cit20">
)
<string-name><surname>Kimura</surname>
,
<given-names>K.</given-names></string-name>
,
<string-name><surname>Konda</surname>
,
<given-names>C.</given-names></string-name>
,
<string-name><surname>Kashiwada</surname>
,
<given-names>N.</given-names></string-name>
,
<string-name><surname>Mikuni</surname>
,
<given-names>M.</given-names></string-name>
,
<string-name><surname>Shimoyama</surname>
,
<given-names>M.</given-names></string-name>
,
<string-name><surname>Kitahara</surname>
,
<given-names>T.</given-names></string-name>
,
<string-name><surname>Kurihara</surname>
,
<given-names>M.</given-names></string-name>
and
<string-name><surname>Inagaki</surname>
,
<given-names>J.</given-names></string-name><article-title>Chemotherapy of abdominal malignant tumors</article-title>
.
<source>Naika</source>
,
<volume>19</volume>
,
<fpage>1314</fpage>
&#x02013;
<lpage>1320</lpage>
(
<year>1967</year>
)(
in Japanese
).
<pub-id pub-id-type="pmid">6079614</pub-id></mixed-citation></ref><ref id="b21"><label>21</label><mixed-citation publication-type="book" id="cit21">
)
<collab collab-type="authors">Japanese Research Society for Gastric Cancer</collab>
,
<chapter-title>Criteria for Evaluating Efficacy of Chemotherapy/Radiation Therapy in the Treatment of Gastric Cancer</chapter-title>
. &#x0201c;
<source>The General Rules for the Gastric Cancer Study</source>
&#x0201d;,
<edition>11th Edition</edition>
,
p.
<fpage>46</fpage>
(
<year>1985</year>
).
<publisher-name>Kanehara Shuppan</publisher-name>
,
Tokyo
(
in Japanese
).
</mixed-citation></ref></ref-list></back></article>